RxDoctor Payments Data

Paul Wise, MD

Colon & Rectal Surgery · Saint Louis, MONPI 1619076056

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $21,233 of the $23,959 with a category attached, or 88.6%. Olympus Corporation accounts for 88.9% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2024 at $18,342 and has fallen 73.1% since, to $4,937 in 2025. Among colon & rectal surgery clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$23,959in general payments, 2019–2025

Across 46 payments — averaging $520.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Olympus Corporation$21K
  • Olympus Corporation Of The Americas$1K
  • AbbVie$410
  • Medtronic$343
  • Stryker$191
  • Davol Inc.$178
  • plus $352 from 5 others
$21,759in research payments, 2019–2025

Across 10 payments — averaging $2175.90 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Janssen Research & Development, LLC$20K
  • Mallinckrodt Enterprises LLC$2K

What the payments were for

  • Consulting fees$21,23389%
  • Travel & lodging$9544%
  • Food & beverage$1,7737%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$23,959 in reported general payments places this provider in the 90th percentile of 36 colon & rectal surgery providers in Missouri.

See all colon & rectal surgery providers in Missouri

Medicare billing

Part B allowed, 2024
$91,340
Medicare patients
182
Services billed
389

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates73$4,816
Sodium Chloride0.9 % Sodium Chloride19$977
Lidocaine15$319
Neomycin Sulfate31$191
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl15$84
Ondansetron OdtOndansetron21$53
Metronidazole33$46

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →